Heart Failure Clinical Trial

Effects of Carvedilol on Health Outcomes in Heart Failure

Summary

The purpose of our study was to determine if a strategy of starting a heart medication (Beta-blocker) before patients leave the hospital and then being seen by a nurse manager would reduce subsequent hospitalizations compared to usual care.

Hypothesis: A nurse-directed heart failure management program with inpatient initiation of beta blockers will improve health outcomes in a vulnerable, predominantly Hispanic and African American population.

View Full Description

Full Description

Heart failure is a leading cause of death and hospitalization in the US. Designing practical approaches to improving heart failure care is therefore a national health priority. One retrospective study suggested that patients taking beta-blockers while hospitalized for heart failure had a lower risk of rehospitalization at 6-months. One prospective study suggested that starting beta blockers among hospitalized heart failure patients is safe and improves compliance. However, improved outcomes of this approach have not been prospectively demonstrated.

Comparison: Inpatient initiation of the beta-blocker carvedilol coupled with outpatient follow-up with a nurse manager was compared to usual care by internists and cardiologists.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

primary hospitalization with heart failure and LVEF < 40%
patient informed consent has been obtained
absence of pulmonary congestion
age > 18 years

Exclusion Criteria:

End-stage renal or hepatic disease
Acute myocardial infarction as primary diagnosis during index hospitalization
Life-expectancy < 6-months
Contraindication to beta blocker use
Current beta-blocker therapy
Planned bypass or valve surgery during index hospitalization

Study is for people with:

Heart Failure

Phase:

Phase 4

Estimated Enrollment:

100

Study ID:

NCT00381030

Recruitment Status:

Completed

Sponsor:

Denver Health and Hospital Authority

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Denver Health Medical Center
Denver Colorado, 80204, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Phase:

Phase 4

Estimated Enrollment:

100

Study ID:

NCT00381030

Recruitment Status:

Completed

Sponsor:


Denver Health and Hospital Authority

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider